Table 4.

Immunologic Features of Kindred No. 2

Fas Mutation% CD4CD8CD19+ cells/Fas-Mediated
TCRα/β+mm3 (%)Apoptosis
% Cell Loss4-150
Patient no. 2 25  3485 (41) 35 
Mother 0.6 135 (6) 25 
Maternal grandfather 0.9 148 (7) 17 
Maternal uncle no. 1 0.7 80 (4) 37 
Father − 0.2 234 (10) 90 
Sister − 0.8 51 (3) ND 
Maternal uncle no. 2 − 0.7 80 (4) 62 
Maternal grandmother − 0.1 89 (6) 63 
Fas Mutation% CD4CD8CD19+ cells/Fas-Mediated
TCRα/β+mm3 (%)Apoptosis
% Cell Loss4-150
Patient no. 2 25  3485 (41) 35 
Mother 0.6 135 (6) 25 
Maternal grandfather 0.9 148 (7) 17 
Maternal uncle no. 1 0.7 80 (4) 37 
Father − 0.2 234 (10) 90 
Sister − 0.8 51 (3) ND 
Maternal uncle no. 2 − 0.7 80 (4) 62 
Maternal grandmother − 0.1 89 (6) 63 

Abbreviation: ND, not done.

F4-150

Percentage of lymphocytes undergoing apoptosis after exposure to the anti-Fas MoAb CH11.

Close Modal

or Create an Account

Close Modal
Close Modal